LU53214A1 - - Google Patents

Info

Publication number
LU53214A1
LU53214A1 LU53214DA LU53214A1 LU 53214 A1 LU53214 A1 LU 53214A1 LU 53214D A LU53214D A LU 53214DA LU 53214 A1 LU53214 A1 LU 53214A1
Authority
LU
Luxembourg
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU53214A1 publication Critical patent/LU53214A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
LU53214D 1966-03-31 1967-03-16 LU53214A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR55903A FR1482102A (fr) 1966-03-31 1966-03-31 Nouveaux dérivés de stéroïdes et procédé de préparation
FR67026A FR5631M (fr) 1966-03-31 1966-06-27
FR97572 1967-03-06

Publications (1)

Publication Number Publication Date
LU53214A1 true LU53214A1 (fr) 1967-05-16

Family

ID=27243062

Family Applications (1)

Application Number Title Priority Date Filing Date
LU53214D LU53214A1 (fr) 1966-03-31 1967-03-16

Country Status (7)

Country Link
US (1) US3925480A (fr)
BE (1) BE695551A (fr)
CH (1) CH472398A (fr)
FR (2) FR1482102A (fr)
GB (1) GB1154424A (fr)
LU (1) LU53214A1 (fr)
NL (1) NL6704645A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920115A (en) * 1988-12-28 1990-04-24 Virginia Commonwealth University Method of lowering LDL cholesterol in blood
IL146223A0 (en) * 1999-04-30 2002-07-25 Arch Dev Corp Steroid derivatives
CN1498222A (zh) * 2001-02-08 2004-05-19 芝加哥大学 类固醇衍生物
DK1392713T3 (da) * 2001-05-03 2008-02-18 Univ Chicago Lever-X-receptoragonister
US7078396B2 (en) * 2001-05-03 2006-07-18 Arch Development Corporation Method of treating disorder related to high cholesterol concentration
US20070197484A1 (en) * 2001-05-03 2007-08-23 Ching Song Method of treating disorder related to high cholesterol concentration
CA2482195A1 (fr) * 2002-04-12 2003-10-23 The University Of Chicago Agonistes de recepteur active frx (farnesoid x receptor)
US20070032464A1 (en) * 2004-10-08 2007-02-08 Shutsung Liao Methods of treating cancers
EP2459581A4 (fr) * 2009-07-29 2012-12-26 Univ Chicago Agonistes du récepteur x du foie

Also Published As

Publication number Publication date
US3925480A (en) 1975-12-09
FR1482102A (fr) 1967-05-26
CH472398A (fr) 1969-05-15
GB1154424A (en) 1969-06-11
DE1618224A1 (de) 1971-03-11
DE1618224B2 (de) 1976-02-05
NL6704645A (fr) 1967-10-02
BE695551A (fr) 1967-08-14
FR5631M (fr) 1967-12-18

Similar Documents

Publication Publication Date Title
FR5631M (fr)
AT281852B (fr)
AU5917865A (fr)
AU1141566A (fr)
AU1534566A (fr)
AU1111066A (fr)
AU1144366A (fr)
AU218666A (fr)
AU1393566A (fr)
BE692116A (fr)
BE675084A (fr)
BE693391A (fr)
BE693387A (fr)
BE693544A (fr)
BE693087A (fr)
BE693049A (fr)
BE692916A (fr)
BE692889A (fr)
BE692818A (fr)
BE692328A (fr)
AU1027866A (fr)
BE692300A (fr)
BE692128A (fr)
BE637138A (fr)
BE691285A (fr)